UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 12
December-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2512111


Registration ID:
572570

Page Number

b70-b73

Share This Article


Jetir RMS

Title

A COMPREHENSIVE REVIEW ON THE IRBESARTAN GASTRORETENTIVE FLOATING TABLETS

Abstract

Irbesartan is an angiotensin II receptor blocker (ARB) commonly used for the treatment of hypertension. Its effectiveness mainly depends on two important factors — it belongs to the Biopharmaceutics Classification System (BCS) Class II category, meaning it has low solubility but high permeability, and it has a narrow absorption window in the upper part of the gastrointestinal (GI) tract. Because its biological half-life ranges between 11 and 15 hours, a sustained release formulation is needed to maintain 24-hour therapeutic action. Conventional tablets often move rapidly through the GI tract, which can lead to incomplete absorption and fluctuating plasma levels. To overcome this issue, gastroretentive drug delivery systems (GRDDS), particularly floating tablets, have been developed. These systems help the tablet remain in the stomach for a longer time, allowing a controlled and continuous release of the drug at its main absorption site. The review also discusses gastric physiology, such as the migrating motor complex, and explains the principles of flotation, both effervescent and non-effervescent. The importance of polymers like HPMC and Carbopol, along with solubility-enhancing techniques such as solid dispersions and cyclodextrin complexes, is also highlighted. Finally, it covers different characterization methods, including in vitro release kinetics and in vivo evaluation using gamma scintigraphy.

Key Words

Irbesartan, Biopharmaceutics Classification, Gastroretentive Drug Delivery Systems, floating tablets

Cite This Article

"A COMPREHENSIVE REVIEW ON THE IRBESARTAN GASTRORETENTIVE FLOATING TABLETS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 12, page no.b70-b73, December-2025, Available :http://www.jetir.org/papers/JETIR2512111.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A COMPREHENSIVE REVIEW ON THE IRBESARTAN GASTRORETENTIVE FLOATING TABLETS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 12, page no. ppb70-b73, December-2025, Available at : http://www.jetir.org/papers/JETIR2512111.pdf

Publication Details

Published Paper ID: JETIR2512111
Registration ID: 572570
Published In: Volume 12 | Issue 12 | Year December-2025
DOI (Digital Object Identifier):
Page No: b70-b73
Country: Yeola/Nashik, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00052

Print This Page

Current Call For Paper

Jetir RMS